Sign in
4

Changes in Ownership

Hepion Pharmaceuticals, Inc. Filed Acc 0001493152-26-048708

Options or other derivatives

  • Chief Financial Officer acquired 1,530,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stetz Gary S. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-10-23 Grant or award : show line 1 in the form Stock Options +1,530,000 2,875,500 D
Loading xslF345X06/ownership.xml…